SCHEMBL3176983

SCHEMBL3176983

CC(=O)NCCNc1cc(NCCNC(C)=O)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 5/20 0.57
CNR1 P21554 1/20 0.48
MALT1 Q9UDY8 1/20 0.47
LTA4H P09960 1/20 0.46
CYP1A2 P05177 4/20 0.46
ALDH1A1 P00352 4/20 0.46
CYP3A4 P08684 3/20 0.46
HSD17B10 Q99714 3/20 0.46
ALOX15 P16050 2/20 0.46
CLK4 Q9HAZ1 2/20 0.46
MAPK1 P28482 1/20 0.46
GPR119 Q8TDV5 1/20 0.45
LMNA P02545 2/20 0.45
MEN1 O00255 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 2/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172079 0.94 ADORA3 (0.51) ADORA3CNR1MALT1LTA4HCYP1A2
SCHEMBL3165040 0.93 ADORA3 (0.53) ADORA3CNR1MALT1LTA4HCYP1A2
SCHEMBL3175971 0.93 ADORA3 (0.56) ADORA3CNR1MALT1LTA4HCYP1A2
SCHEMBL3175682 0.93 ADORA3 (0.50) ADORA3CNR1MALT1LTA4HCYP1A2
SCHEMBL3163677 0.92 ADORA3 (0.49) ADORA3CNR1MALT1LTA4HCYP1A2
SCHEMBL3175775 0.91 ADORA3 (0.48) ADORA3CNR1MALT1CYP1A2ALDH1A1
SCHEMBL3163156 0.89 RAB9A (0.48) ADORA3MALT1LMNAMEN1NPC1
SCHEMBL3171192 0.89 ADORA3 (0.47) ADORA3MALT1CYP1A2ALDH1A1CYP3A4
SCHEMBL3171606 0.89 ADORA3 (0.46) ADORA3MALT1LTA4HALDH1A1MEN1
SCHEMBL3172697 0.89 NPC1 (0.47) ADORA3MALT1CYP1A2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed